Hudock Inc’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $246K | Buy |
1,767
+2
| +0.1% | +$280 | 0.04% | 173 |
|
|
2025
Q4 | $217K | Buy |
+1,765
| New | +$214K | 0.03% | 183 |
|
|
2022
Q4 | – | Sell |
-2,328
| Closed | -$143K | – | 354 |
|
|
2022
Q3 | $143K | Buy |
2,328
+5
| +0.2% | +$315 | 0.05% | 163 |
|
|
2022
Q2 | $143K | Sell |
2,323
-121
| -5% | -$7.49K | 0.05% | 169 |
|
|
2022
Q1 | $145K | Buy |
2,444
+305
| +14% | +$19.5K | 0.04% | 180 |
|
|
2021
Q4 | $155K | Buy |
2,139
+3
| +0.1% | +$207 | 0.04% | 181 |
|
|
2021
Q3 | $149K | Buy |
2,136
+4
| +0.2% | +$281 | 0.04% | 184 |
|
|
2021
Q2 | $146K | Buy |
2,132
+4
| +0.2% | +$267 | 0.04% | 181 |
|
|
2021
Q1 | $137K | Sell |
2,128
-309
| -13% | -$19.9K | 0.04% | 177 |
|
|
2020
Q4 | $142K | Buy |
2,437
+2,199
| +924% | +$133K | 0.05% | 174 |
|
|
2020
Q3 | $15K | Hold |
238
| – | – | 0.01% | 417 |
|
|
2020
Q2 | $18K | Buy |
238
+25
| +12% | +$1.92K | 0.01% | 385 |
|
|
2020
Q1 | $15K | Sell |
213
-169
| -44% | -$11.7K | 0.01% | 363 |
|
|
2019
Q4 | $24K | Buy |
382
+2
| +0.5% | +$130 | 0.01% | 319 |
|
|
2019
Q3 | $24K | Buy |
380
+2
| +0.5% | +$131 | 0.01% | 325 |
|
|
2019
Q2 | $25K | Buy |
378
+1
| +0.3% | +$66 | 0.01% | 316 |
|
|
2019
Q1 | $24K | Buy |
377
+27
| +8% | +$1.79K | 0.01% | 311 |
|
|
2018
Q4 | $21K | Hold |
350
| – | – | 0.01% | 311 |
|
|
2018
Q3 | $27K | Hold |
350
| – | – | 0.01% | 315 |
|
|
2018
Q2 | $24K | Buy |
350
+150
| +75% | +$10.6K | 0.01% | 320 |
|
|
2018
Q1 | $15K | Sell |
200
-106
| -35% | -$8.43K | 0.01% | 393 |
|
|
2017
Q4 | $21K | Buy |
306
+1
| +0.3% | +$76 | 0.01% | 341 |
|
|
2017
Q3 | $24K | Hold |
305
| – | – | 0.01% | 325 |
|
|
2017
Q2 | $21K | Sell |
305
-361
| -54% | -$24K | 0.01% | 323 |
|
|
2017
Q1 | $45K | Sell |
666
-231
| -26% | -$16.2K | 0.02% | 235 |
|
|
2016
Q4 | $64K | Sell |
897
-10
| -1% | -$743 | 0.04% | 191 |
|
|
2016
Q3 | $71K | Buy |
907
+4
| +0.4% | +$325 | 0.04% | 184 |
|
|
2016
Q2 | $75K | Buy |
903
+32
| +4% | +$2.84K | 0.04% | 181 |
|
|
2016
Q1 | $80K | Sell |
871
-82
| -9% | -$7.39K | 0.04% | 169 |
|
|
2015
Q4 | $96K | Buy |
953
+22
| +2% | +$2.29K | 0.04% | 138 |
|
|
2015
Q3 | $91K | Buy |
931
+300
| +48% | +$33.3K | 0.04% | 139 |
|
|
2015
Q2 | $73K | Hold |
631
| – | – | 0.03% | 169 |
|
|
2015
Q1 | $62K | Sell |
631
-470
| -43% | -$47.7K | 0.03% | 192 |
|
|
2014
Q4 | $104K | Buy |
1,101
+801
| +267% | +$82.8K | 0.05% | 140 |
|
|
2014
Q3 | $32K | Sell |
300
-140
| -32% | -$13.7K | 0.02% | 260 |
|
|
2014
Q2 | $36K | Buy |
440
+360
| +450% | +$28K | 0.04% | 255 |
|
|
2014
Q1 | $6K | Buy |
+80
| New | +$6.27K | 0.01% | 425 |
|
Other funds holding GILD
VCM
VPM
Hudock Inc's GILD Position: Q1 2026 in Review
Hudock Inc increased its Gilead Sciences (GILD) stake by 0.11% in Q1 2026, buying an estimated $280 and bringing the position to 1,767 shares worth $246K. The position accounts for 0.04% of the portfolio, ranked #173.
Hudock Inc first reported a position in GILD in Q1 2014 and has held it in 37 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Hudock Inc held 1,767 shares of Gilead Sciences worth $246K as of Q1 2026.
- Hudock Inc bought 2 Gilead Sciences shares in Q1 2026, an estimated $280.
- Gilead Sciences made up 0.04% of Hudock Inc's portfolio in Q1 2026, its #173 holding.
- Hudock Inc first reported a position in Gilead Sciences in Q1 2014 and has held it in 37 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Hudock Inc's 13F filing for Q1 2026, filed 13 May 2026.